During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.32 million, with the beta value of the company hitting -1.76. At the end
Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting -1.74. At the close of
In last trading session, Tempest Therapeutics Inc (NASDAQ:TPST) saw 0.41 million shares changing hands with its beta currently measuring -1.73. Company’s recent per share price
During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.4 million, with the beta value of the company hitting -1.63. At the end
Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting -1.58. At the close of
In last trading session, Tempest Therapeutics Inc (NASDAQ:TPST) saw 0.46 million shares changing hands with its beta currently measuring -1.70. Company’s recent per share price
Tempest Therapeutics Inc (NASDAQ:TPST) has a beta value of -1.72 and has seen 2.51 million shares traded in the last trading session. The company, currently
During the recent session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.79 million, with the beta value of the company hitting -1.74. At the last
In the last trading session, 16.65 million shares of the Tempest Therapeutics Inc (NASDAQ:TPST) were traded, and its beta was -1.74. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
